←Back to structures
CAKLQF020000008.1__CAH1081914.1__SAMEA5780031_01809__00054
Bact-VirCAKLQF020000008.1__CAH1081914.1__SAMEA5780031_01809__00054
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
medium
residues 82-161
Domain cluster:
rep: CAKLQF020000010.1__CAH1085058.1__SAMEA5780031_02153__00098__D86-163
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF00866.25 best | Ring_hydroxyl_B | 28.3 | 2.40e-06 | 90.0% | 49.3% |
CATH (80)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.90 | 81.0 | 6.39e-01 | 100.0% | 51.4% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.89 | 84.0 | 6.39e-01 | 100.0% | 49.1% |
| 2ckfB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 82.0 | 6.19e-01 | 100.0% | 47.1% |
| 2bmoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 81.0 | 5.91e-01 | 100.0% | 42.8% |
| 1tp6A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 66.0 | 5.56e-01 | 85.0% | 51.6% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 68.0 | 5.66e-01 | 85.0% | 52.7% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 66.0 | 5.53e-01 | 83.7% | 53.4% |
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 77.0 | 6.06e-01 | 98.8% | 51.6% |
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 66.0 | 5.49e-01 | 83.7% | 54.5% |
| 3b8lA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 74.0 | 6.04e-01 | 97.5% | 56.0% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 73.0 | 5.82e-01 | 95.0% | 52.0% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 67.0 | 5.43e-01 | 87.5% | 54.2% |
| 3b7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 60.0 | 5.20e-01 | 82.5% | 52.5% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.80 | 64.0 | 5.20e-01 | 85.0% | 53.5% |
| 2f86B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 61.0 | 5.17e-01 | 81.2% | 51.9% |
| 3ub1D02 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 56.0 | 4.95e-01 | 80.0% | 51.8% |
| 5cxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 63.0 | 5.20e-01 | 90.0% | 50.0% |
| 1tuhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 65.0 | 5.41e-01 | 96.2% | 53.4% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 64.0 | 5.39e-01 | 86.3% | 55.1% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.79 | 64.0 | 5.25e-01 | 86.3% | 52.2% |
| 2obdA01 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.79 | 72.0 | 4.84e-01 | 100.0% | 35.7% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 63.0 | 5.30e-01 | 85.0% | 53.1% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 68.0 | 5.25e-01 | 92.5% | 47.0% |
| 2rfrA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 64.0 | 5.07e-01 | 87.5% | 46.8% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 64.0 | 5.40e-01 | 91.3% | 54.7% |
| 2bngC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 60.0 | 4.90e-01 | 92.5% | 46.4% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 62.0 | 5.32e-01 | 85.0% | 57.9% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 66.0 | 5.40e-01 | 92.5% | 52.5% |
| 1of5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 60.0 | 4.77e-01 | 82.5% | 46.8% |
| 1wnhA02 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 58.0 | 5.00e-01 | 85.0% | 52.5% |
| 3mg1B02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 58.0 | 4.91e-01 | 83.7% | 50.4% |
| 3ke7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 61.0 | 5.07e-01 | 87.5% | 50.4% |
| 1p4tA00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.76 | 70.0 | 5.56e-01 | 100.0% | 80.6% |
| 3k0zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 58.0 | 4.66e-01 | 93.8% | 43.0% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 59.0 | 5.05e-01 | 85.0% | 51.9% |
| 1vqqA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.75 | 56.0 | 5.06e-01 | 100.0% | 57.8% |
| 2r4iA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 59.0 | 5.08e-01 | 85.0% | 54.5% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 57.0 | 4.59e-01 | 81.2% | 85.6% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 61.0 | 5.15e-01 | 91.3% | 53.4% |
| 3g8zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 60.0 | 5.13e-01 | 96.2% | 54.7% |
| 3eyrA00 | 3.15.10.40 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Uncharacterised protein PF07273 family, DUF1439 | 0.74 | 68.0 | 5.24e-01 | 100.0% | 51.5% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 63.0 | 5.24e-01 | 92.5% | 54.9% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 52.0 | 4.52e-01 | 77.5% | 50.0% |
| 3fgyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 62.0 | 5.13e-01 | 96.2% | 54.1% |
| 3h4zB03 | 3.15.10.50 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › | 0.73 | 65.0 | 4.94e-01 | 100.0% | 72.3% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 60.0 | 5.04e-01 | 92.5% | 54.3% |
| 4x2oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 57.0 | 4.36e-01 | 83.7% | 50.3% |
| 4u13A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 49.0 | 4.42e-01 | 77.5% | 51.4% |
| 1bp1A01 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.73 | 65.0 | 5.00e-01 | 100.0% | 67.2% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 60.0 | 4.95e-01 | 95.0% | 50.3% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 54.0 | 4.64e-01 | 80.0% | 52.0% |
| 1s5aB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 63.0 | 5.11e-01 | 96.2% | 53.1% |
| 3fidA00 | 2.40.128.140 | Mainly Beta › Beta Barrel › Lipocalin › Outer membrane protein | 0.71 | 60.0 | 4.03e-01 | 92.5% | 58.8% |
| 2rckA01 | 3.15.10.30 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › TULIP domain | 0.71 | 61.0 | 4.54e-01 | 98.8% | 61.0% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 61.0 | 5.15e-01 | 95.0% | 58.5% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 59.0 | 5.00e-01 | 93.8% | 56.1% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 57.0 | 4.83e-01 | 91.3% | 53.3% |
| 4ec6A00 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 52.0 | 4.74e-01 | 82.5% | 80.7% |
| 2i9wA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 50.0 | 3.86e-01 | 80.0% | 35.8% |
| 2uvaG09 | 2.40.128.700 | Mainly Beta › Beta Barrel › Lipocalin › | 0.65 | 49.0 | 4.32e-01 | 80.0% | 88.8% |
| 1t17A00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.65 | 58.0 | 4.69e-01 | 97.5% | 69.6% |
| 2lyxA00 | 3.10.450.390 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Protein of unknown function DUF3889 | 0.64 | 44.0 | 4.35e-01 | 88.7% | 66.7% |
| 2w4yA00 | 2.40.160.220 | Mainly Beta › Beta Barrel › Porin › | 0.61 | 46.0 | 4.07e-01 | 81.2% | 64.8% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.61 | 54.0 | 4.28e-01 | 100.0% | 52.4% |
| 8eisA01 | 2.70.170.10 | Mainly Beta › Distorted Sandwich › Acetylcholine Binding Protein; Chain: A, › Neurotransmitter-gated ion-channel ligand-binding domain | 0.60 | 54.0 | 3.98e-01 | 98.8% | 65.5% |
| 2oq8A00 | 2.60.40.2930 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.60 | 48.0 | 3.87e-01 | 86.3% | 50.0% |
| 1af6A00 | 2.40.170.10 | Mainly Beta › Beta Barrel › Maltoporin; Chain A › Porin, LamB type | 0.59 | 49.0 | 3.12e-01 | 91.3% | 58.7% |
| 1ut7B01 | 2.170.150.80 | Mainly Beta › Beta Complex › Metal Binding Protein, Guanine Nucleotide Exchange Factor; Chain A › NAC domain | 0.59 | 44.0 | 3.89e-01 | 87.5% | 52.0% |
| 2gtlO02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.58 | 50.0 | 4.02e-01 | 97.5% | 61.3% |
| 2gtlM02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.58 | 50.0 | 4.06e-01 | 100.0% | 58.4% |
| 6secA03 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.58 | 49.0 | 3.48e-01 | 100.0% | 37.0% |
| 4jhcB00 | 3.90.950.10 | Alpha Beta › Alpha-Beta Complex › Maf protein › | 0.57 | 50.0 | 3.83e-01 | 96.2% | 91.2% |
| 4akrA02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.56 | 48.0 | 3.97e-01 | 95.0% | 59.2% |
| 6yfiB01 | 3.30.380.10 | Alpha Beta › 2-Layer Sandwich › MS2 Viral Coat Protein › MS2 Viral Coat Protein | 0.56 | 43.0 | 3.61e-01 | 82.5% | 55.6% |
| 1b7eA01 | 3.90.350.10 | Alpha Beta › Alpha-Beta Complex › Transposase Inhibitor Protein From Tn5; Chain A, domain 1 › Transposase Inhibitor Protein From Tn5; Chain A, domain 1 | 0.53 | 37.0 | 2.70e-01 | 75.0% | 24.8% |
| 3butA00 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.52 | 46.0 | 4.00e-01 | 100.0% | 92.8% |
| 7a0hA02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.52 | 44.0 | 3.43e-01 | 93.8% | 75.9% |
| 1b78A00 | 3.90.950.10 | Alpha Beta › Alpha-Beta Complex › Maf protein › | 0.51 | 44.0 | 3.39e-01 | 95.0% | 98.4% |
| 6f1uK02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.51 | 42.0 | 3.54e-01 | 92.5% | 76.6% |
| 3bf2A00 | 3.30.160.150 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Lipoprotein like domain | 0.51 | 43.0 | 3.76e-01 | 95.0% | 86.4% |
ECOD (91)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3056323 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.93 | 88.0 | 6.80e-01 | 100.0% | 51.3% |
| 3970009 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.92 | 89.0 | 6.65e-01 | 100.0% | 47.3% |
| 4283272 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.91 | 87.0 | 6.54e-01 | 100.0% | 47.1% |
| 4676601 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.90 | 84.0 | 6.37e-01 | 100.0% | 46.7% |
| 5009713 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.90 | 80.0 | 6.17e-01 | 95.0% | 46.9% |
| 4608992 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.89 | 83.0 | 6.43e-01 | 100.0% | 50.0% |
| 3280394 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.89 | 68.0 | 5.73e-01 | 85.0% | 51.2% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.87 | 69.0 | 5.80e-01 | 85.0% | 52.8% |
| 1558628 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.87 | 70.0 | 5.68e-01 | 85.0% | 82.9% |
| 2834504 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.86 | 81.0 | 6.33e-01 | 100.0% | 51.9% |
| 1674783 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.86 | 69.0 | 5.65e-01 | 85.0% | 52.5% |
| 4312776 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.86 | 81.0 | 6.32e-01 | 100.0% | 51.9% |
| 3281675 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.86 | 66.0 | 5.92e-01 | 80.0% | 62.9% |
| 3958251 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.86 | 68.0 | 5.36e-01 | 83.7% | 43.5% |
| 3277629 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.86 | 65.0 | 5.44e-01 | 81.2% | 50.4% |
| 3958465 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.85 | 63.0 | 5.02e-01 | 77.5% | 42.0% |
| 4152363 | 243.1.1.115 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29733 | 0.85 | 67.0 | 5.72e-01 | 85.0% | 54.5% |
| 3963115 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.85 | 65.0 | 5.26e-01 | 81.2% | 45.5% |
| 3941713 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.85 | 65.0 | 5.32e-01 | 81.2% | 57.1% |
| 3959534 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.84 | 65.0 | 5.37e-01 | 81.2% | 48.9% |
| 3962739 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.84 | 65.0 | 5.17e-01 | 81.2% | 44.0% |
| 5059048 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.84 | 66.0 | 5.67e-01 | 83.7% | 54.5% |
| 3291726 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.84 | 65.0 | 5.10e-01 | 81.2% | 44.2% |
| 3957821 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.84 | 65.0 | 5.50e-01 | 82.5% | 81.2% |
| 5022156 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.83 | 67.0 | 5.47e-01 | 87.5% | 49.3% |
| 6380 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.83 | 77.0 | 6.06e-01 | 98.8% | 51.6% |
| 4472109 | 243.1.1.103 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF30257 | 0.83 | 66.0 | 5.67e-01 | 85.0% | 55.8% |
| 3952458 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.82 | 65.0 | 5.43e-01 | 85.0% | 51.5% |
| 3974899 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.82 | 67.0 | 5.36e-01 | 86.3% | 49.7% |
| 6408 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.82 | 73.0 | 5.81e-01 | 95.0% | 51.7% |
| 4315252 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.82 | 67.0 | 5.36e-01 | 86.3% | 49.7% |
| 399927 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.82 | 67.0 | 5.27e-01 | 86.3% | 47.1% |
| 5040972 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.81 | 61.0 | 6.35e-01 | 81.2% | 84.0% |
| 5003871 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.81 | 67.0 | 5.47e-01 | 91.3% | 50.0% |
| 4254866 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.81 | 62.0 | 5.25e-01 | 80.0% | 52.0% |
| 3970236 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.80 | 67.0 | 5.47e-01 | 88.7% | 52.5% |
| 4016448 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.80 | 70.0 | 5.61e-01 | 92.5% | 51.0% |
| 3959285 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.80 | 61.0 | 6.06e-01 | 81.2% | 81.0% |
| 3698353 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 62.0 | 5.27e-01 | 82.5% | 53.6% |
| 2722108 | 243.1.1.67 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Cds6_C | 0.79 | 60.0 | 5.05e-01 | 78.8% | 50.8% |
| 3517998 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.79 | 62.0 | 4.57e-01 | 83.7% | 72.5% |
| 3296374 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 62.0 | 4.78e-01 | 87.5% | 40.0% |
| 135548 | 243.1.1.19 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF3804 | 0.79 | 64.0 | 5.38e-01 | 86.3% | 54.7% |
| 3214004 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.78 | 57.0 | 5.26e-01 | 85.0% | 61.0% |
| 4020443 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.78 | 61.0 | 5.20e-01 | 87.5% | 53.7% |
| 3828738 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.77 | 63.0 | 5.03e-01 | 87.5% | 46.5% |
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.77 | 61.0 | 5.28e-01 | 83.7% | 84.2% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.77 | 62.0 | 5.32e-01 | 85.0% | 57.9% |
| 3288890 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 57.0 | 4.86e-01 | 78.8% | 50.8% |
| 4074364 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 58.0 | 4.91e-01 | 85.0% | 49.2% |
| 3407993 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.77 | 60.0 | 4.59e-01 | 83.7% | 73.9% |
| 3731745 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.76 | 64.0 | 5.03e-01 | 90.0% | 46.9% |
| 137634 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.76 | 59.0 | 5.05e-01 | 85.0% | 51.9% |
| 3459974 | 243.1.1.45 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › S6PP_C | 0.76 | 69.0 | 5.45e-01 | 100.0% | 50.9% |
| 3278323 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.76 | 61.0 | 5.08e-01 | 85.0% | 52.3% |
| 3591282 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 58.0 | 5.03e-01 | 83.7% | 54.6% |
| 6405 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.75 | 61.0 | 5.17e-01 | 91.3% | 53.8% |
| 4865157 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.74 | 55.0 | 4.82e-01 | 77.5% | 80.2% |
| 4955261 | 5.1.2.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 5-bladed | 0.74 | 52.0 | 3.41e-01 | 72.5% | 28.7% |
| 3262201 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 68.0 | 5.52e-01 | 100.0% | 55.2% |
| 137905 | 883.1.1.5 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › DUF1439 | 0.74 | 67.0 | 5.21e-01 | 100.0% | 52.6% |
| 3734807 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 64.0 | 4.96e-01 | 97.5% | 44.7% |
| 1790173 | 243.1.1.39 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TraH_VirB8-like | 0.74 | 57.0 | 4.90e-01 | 86.3% | 52.3% |
| 2841938 | 243.1.1.81 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF27546 | 0.74 | 60.0 | 4.60e-01 | 88.7% | 75.7% |
| 3736480 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 61.0 | 4.87e-01 | 90.0% | 55.5% |
| 3545097 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.73 | 65.0 | 4.95e-01 | 100.0% | 54.7% |
| 3807566 | 331.3.1.28 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › DUF220 | 0.73 | 65.0 | 5.19e-01 | 98.8% | 91.6% |
| 3289158 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 52.0 | 4.69e-01 | 83.7% | 55.5% |
| 3432676 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.72 | 54.0 | 4.41e-01 | 85.0% | 43.2% |
| 3651043 | 243.3.1.47 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF7074 | 0.71 | 52.0 | 4.94e-01 | 81.2% | 65.3% |
| 3808862 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.70 | 56.0 | 4.70e-01 | 88.7% | 50.7% |
| 3967804 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 59.0 | 5.39e-01 | 93.8% | 72.4% |
| 3290399 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 56.0 | 4.69e-01 | 100.0% | 51.1% |
| 3429034 | 11.1.1.51 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like › LEA_2 | 0.69 | 49.0 | 3.85e-01 | 75.0% | 97.0% |
| 861 | 9.3.1.3 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Eryth_link_C | 0.66 | 59.0 | 5.03e-01 | 98.8% | 76.6% |
| 4025319 | 881.1.1.2 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1 | 0.65 | 48.0 | 3.85e-01 | 81.2% | 39.9% |
| 3226411 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.64 | 52.0 | 4.21e-01 | 87.5% | 52.0% |
| 4991405 | 2004.1.1.198 ↗ | a/b three-layered sandwiches › P-loop domains-like › P-loop domains-related › P-loop containing nucleoside triphosphate hydrolases › AAA_23 | 0.64 | 55.0 | 3.52e-01 | 95.0% | 48.4% |
| 3230449 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.63 | 48.0 | 3.97e-01 | 83.7% | 46.5% |
| 3697493 | 5.1.5.70 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 8-bladed › TFIIIC_delta | 0.61 | 47.0 | 3.07e-01 | 85.0% | 56.7% |
| 4371290 | 9.3.1.3 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Eryth_link_C | 0.61 | 54.0 | 4.67e-01 | 98.8% | 86.3% |
| 4097328 | 9.3.1.3 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Eryth_link_C | 0.61 | 55.0 | 4.72e-01 | 100.0% | 75.2% |
| 3248448 | 1116.1.1.0 ↗ | a+b two layers › Polycystin-mucolipin domain › Polycystin-mucolipin domain › Polycystin-mucolipin domain | 0.61 | 45.0 | 3.41e-01 | 80.0% | 72.5% |
| 4646283 | 5084.8.1.1 ↗ | beta barrels › Outer membrane meander beta-barrels › Usher PapC translocation pore › Usher PapC translocation pore › Usher | 0.60 | 43.0 | 2.71e-01 | 91.3% | 13.5% |
| 3271615 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.59 | 44.0 | 2.78e-01 | 80.0% | 14.5% |
| 3807704 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.59 | 53.0 | 4.29e-01 | 100.0% | 86.7% |
| 4208285 | 5084.5.2.1 ↗ | beta barrels › Outer membrane meander beta-barrels › Porins › Maltoporin-like › LamB | 0.58 | 48.0 | 3.41e-01 | 93.8% | 50.0% |
| 3182613 | 243.1.1.44 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MBA1 | 0.58 | 44.0 | 3.29e-01 | 83.7% | 34.1% |
| 3212364 | 5.1.5.27 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 8-bladed › APEH_N | 0.56 | 49.0 | 3.09e-01 | 100.0% | 98.4% |
| 4323146 | 7504.1.1.1 ↗ | a/b three-layered sandwiches › ITPase-like › ITPase-like › ITPase-like › Ham1p_like | 0.55 | 46.0 | 3.52e-01 | 93.8% | 91.6% |
| 5017990 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.52 | 38.0 | 3.42e-01 | 77.5% | 81.8% |